Processa Pharmaceuticals Files Prospectus For Offering 306.574M Common Shares On Behalf Of Selling Shareholders

Benzinga Newsdesk www.benzinga.com Neutral 92.3%

Neg 0% Neu 92.3% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1533743/000114036126039267/ny20083166x1_pre14a.htm

Comments

No comments yet. Be the first!